Get updates on COVID-19 research at COVID-19 Resource
Crop Biotech Update

EFSA on Placing on the Market GM Maize MON 88017

November 11, 2011

The European Food Safety Authority published a scientific report on the evaluation for risk assessment of genetically modified (GM) maize MON 88017 for placing on the EU market. In the report, the EFSA GMO Panel "considered the GM maize unlikely to have any adverse effect on the environment, except for the possible resistance evolution to the Cry3Bb1 protein in coleopteran target pests; resistance evolution may lead to altered pest control practices that may cause adverse environmental effects."

In addition, the panel recommended the use of glyphosate in the planting of MON 88017, the deployment of insect resistance management strategies and to monitor the field for (1) possible resistance evolution to the Cry3Bb1 protein in coleopteran target pests, (2) changes in botanical diversity within fields due to novel herbicide regimes, and (3) resistance evolution to glyphosate in weeds due to novel herbicide regimes

In conclusion, the Panel determined "that information available for maize MON 88017 addresses the scientific comments raised by Member States and that maize MON 88017, is as safe as its conventional counterpart and commercial maize varieties with respect to potential adverse effects on human and animal health."

See the original article at http://www.efsa.europa.eu/en/efsajournal/pub/2428.htm